- Home
- PROK vs MGF Comparison
PROK vs MGF Comparison
Compare PROK & MGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- MGF
- Stock Information
- Founded
- PROK 2015
- MGF 1987
- Country
- PROK United States
- MGF United States
- Employees
- PROK N/A
- MGF N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- MGF Trusts Except Educational Religious and Charitable
- Sector
- PROK Health Care
- MGF Finance
- Exchange
- PROK Nasdaq
- MGF Nasdaq
- Market Cap
- PROK 94.9M
- MGF 100.1M
- IPO Year
- PROK N/A
- MGF N/A
- Fundamental
- Price
- PROK $0.98
- MGF $3.06
- Analyst Decision
- PROK Buy
- MGF
- Analyst Count
- PROK 4
- MGF 0
- Target Price
- PROK $5.00
- MGF N/A
- AVG Volume (30 Days)
- PROK 522.0K
- MGF 104.4K
- Earning Date
- PROK 05-12-2025
- MGF 01-01-0001
- Dividend Yield
- PROK N/A
- MGF 7.64%
- EPS Growth
- PROK N/A
- MGF N/A
- EPS
- PROK N/A
- MGF N/A
- Revenue
- PROK $306,000.00
- MGF N/A
- Revenue This Year
- PROK $54.34
- MGF N/A
- Revenue Next Year
- PROK N/A
- MGF N/A
- P/E Ratio
- PROK N/A
- MGF N/A
- Revenue Growth
- PROK N/A
- MGF N/A
- 52 Week Low
- PROK $0.46
- MGF $2.91
- 52 Week High
- PROK $3.43
- MGF $3.46
- Technical
- Relative Strength Index (RSI)
- PROK 65.88
- MGF 49.40
- Support Level
- PROK $0.75
- MGF $3.05
- Resistance Level
- PROK $0.82
- MGF $3.09
- Average True Range (ATR)
- PROK 0.07
- MGF 0.03
- MACD
- PROK 0.03
- MGF 0.00
- Stochastic Oscillator
- PROK 88.17
- MGF 57.14
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About MGF MFS Government Markets Income Trust
MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.